Journal of Cancer Therapy

Volume 2, Issue 2 (June 2011)

ISSN Print: 2151-1934   ISSN Online: 2151-1942

Google-based Impact Factor: 0.30  Citations  h5-index & Ranking

Early Diagnosis of Cardiac Toxicity Related to Antineoplastic Treatment

HTML  Download Download as PDF (Size: 144KB)  PP. 161-166  
DOI: 10.4236/jct.2011.22019    4,905 Downloads   8,660 Views  Citations

Affiliation(s)

ABSTRACT

Background: breast cancer because of radiotherapy and/or chemotherapy causes cardiac disease, often it occurs on women just affected by hypertension and/or diabetes. All these conditions may affect left ventricular (LV) geometry, mass and diastolic function. The purpose of this study is to early detect these affections to improve heart failure prevention. Patients and methods: 134 women, affected by breast cancer, underwent to conventional transthoracic echocar-diography (TTE) and pulse wave tissue Doppler imaging (PW-TDI). A control group (CG) of 80 women unaffected by breast cancer, hypertension and diabetes was enrolled. Results: 54 of 134 women (40.2%), were affected by hypertension or diabetes too (Prone Group = PG), 8 by both, 80 (59.8%) were free (FG). Mean age of all patients was 45.4 years. The rates of LV eccentric hypertrophy and LV distolic dysfunction were statistically significant higher on FG group than controls, and on PG group than FG group. Conclusions: an abnormal LV diastolic function is more common among women affected by breast cancer after treatment than in general population, the same for LV eccentric hypertrophy but at a lower rate. 40% of women were affected by hypertension, diabetes or both, and as expected they have a higher rate of LV eccentric hypertrophy and diastolic dysfunction. This high prevalence of LV eccentric hypertrophy and diastolic dysfunction, on asymptomatic women, affected by breast cancer, is a predictor of heart failure; Doppler-echo techniques may be helpful in early diagnosis.

Share and Cite:

M. Maiello, R. Sharma, M. Ciccone, H. Reddy and P. Palmiero, "Early Diagnosis of Cardiac Toxicity Related to Antineoplastic Treatment," Journal of Cancer Therapy, Vol. 2 No. 2, 2011, pp. 161-166. doi: 10.4236/jct.2011.22019.

Cited by

[1] Comprehensive Invited Review From molecular mechanisms to clinical management of antineoplastic drug-induced cardiovascular toxicity: A translational …
2019
[2] From Molecular Mechanisms to Clinical Management of Antineoplastic Drug-Induced Cardiovascular Toxicity: A Translational Overview
2017
[3] Recent advances on pathophysiology, diagnostic and therapeutic insights in cardiac dysfunction induced by antineoplastic drugs
BioMed Research International, 2015
[4] Vascular Events during Chemotherapy in Treatment of Germ Cell Testicular Cancer
2015
[5] Cardiotoxicity of antineoplastic agents: what is the present and future role for imaging?
Current oncology reports, 2014
[6] Role of echocardiography in monitoring of cardiac toxicity of cancer pharmacotherapy. Expert consensus statement of the Polish Clinical Forum for Cardiovascular …
2014
[7] Współczesna rola echokardiografii w monitorowaniu kardiotoksyczności leków przeciwnowotworowych. Stanowisko grupy ekspertów polskiego Klinicznego …
Kardiol Pol, 2014
[8] Use of echocardiography to evaluate the cardiac effects of therapies used in cancer treatment: what do we know?
Journal of the American …, 2012

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.